Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Gene therapy: new "magic bullets" to prevent ocular scarring.

    Khaw PT, Cambrey AD, Limb GA, Daniels JT.

    Br J Ophthalmol. 2002 May;86(5):490-2. No abstract available. PMID: 11973239 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene therapy in ocular diseases.

    Singh VK, Tripathi P.

    Indian J Ophthalmol. 2002 Sep;50(3):173-81. Review.PMID: 12355690 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Nonviral ocular gene therapy: assessment and future directions.

    Conley SM, Cai X, Naash MI.

    Curr Opin Mol Ther. 2008 Oct;10(5):456-63. Review.PMID: 18830921 [PubMed - indexed for MEDLINE]Related articles

    4.

    Gene therapy for ocular disease.

    Bennett J, Maguire AM.

    Mol Ther. 2000 Jun;1(6):501-5. Review. No abstract available. PMID: 10933974 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Ocular drug delivery: molecules, cells, and genes.

    Liu X, Brandt CR, Rasmussen CA, Kaufman PL.

    Can J Ophthalmol. 2007 Jun;42(3):447-54. Review.PMID: 17508043 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.

    Campochiaro PA.

    Gene Ther. 2006 Mar;13(6):559-62. Review.PMID: 16195702 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ocular gene therapy: a review of nonviral strategies.

    Andrieu-Soler C, Bejjani RA, de Bizemont T, Normand N, BenEzra D, Behar-Cohen F.

    Mol Vis. 2006 Oct 30;12:1334-47. Review.PMID: 17110916 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.

    Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, York-Defalco C, Dean NM, Schultz GS, Khaw PT.

    Gene Ther. 2003 Jan;10(1):59-71.PMID: 12525838 [PubMed - indexed for MEDLINE]Related articles

    9.

    Controlling vascular endothelial growth factor: therapies for ocular diseases associated with neovascularization.

    Marano RJ, Rakoczy PE.

    Adv Exp Med Biol. 2006;572:303-7. Review. No abstract available. PMID: 17249588 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Gene therapy prospects in ophthalmology]

    Stopa M.

    Klin Oczna. 2002;104(3-4):289-92. Review. Polish. PMID: 12608321 [PubMed - indexed for MEDLINE]Related articles

    11.

    Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.

    Ralph GS, Binley K, Wong LF, Azzouz M, Mazarakis ND.

    Clin Sci (Lond). 2006 Jan;110(1):37-46. Review.PMID: 16336203 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recent developments in ocular gene therapy.

    Borrás T.

    Exp Eye Res. 2003 Jun;76(6):643-52. Review.PMID: 12742346 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prospects of gene therapy for ocular diseases.

    Chatterjee PR, Datta H, Sarkar K.

    J Indian Med Assoc. 2000 Dec;98(12):746-7. No abstract available. PMID: 11394472 [PubMed - indexed for MEDLINE]Related articles

    14.

    Electrically assisted ocular gene therapy.

    Bejjani RA, Andrieu C, Bloquel C, Berdugo M, BenEzra D, Behar-Cohen F.

    Surv Ophthalmol. 2007 Mar-Apr;52(2):196-208. Review.PMID: 17355857 [PubMed - indexed for MEDLINE]Related articles

    15.

    Gene therapy progress and prospects: the eye.

    Bainbridge JW, Tan MH, Ali RR.

    Gene Ther. 2006 Aug;13(16):1191-7. Epub 2006 Jul 13. Review.PMID: 16838031 [PubMed - indexed for MEDLINE]Related articles

    16.

    Non-viral ocular gene therapy: potential ocular therapeutic avenues.

    Bloquel C, Bourges JL, Touchard E, Berdugo M, BenEzra D, Behar-Cohen F.

    Adv Drug Deliv Rev. 2006 Nov 15;58(11):1224-42. Epub 2006 Sep 16. Review.PMID: 17095114 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ocular gene therapy. From fantasy to foreseeable reality.

    Zack DJ.

    Arch Ophthalmol. 1993 Nov;111(11):1477-9. No abstract available. PMID: 8240099 [PubMed - indexed for MEDLINE]Related articles

    18.

    Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.

    Sanders NN, Peeters L, Lentacker I, Demeester J, De Smedt SC.

    J Control Release. 2007 Oct 8;122(3):226-35. Epub 2007 May 13. Review.PMID: 17574287 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.

    de la Fuente M, Seijo B, Alonso MJ.

    Gene Ther. 2008 May;15(9):668-76. Epub 2008 Feb 28.PMID: 18305575 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ocular gene therapy: quo vadis?

    Hauswirth WW, Beaufrere L.

    Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2821-6. Review. No abstract available. PMID: 10967033 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data